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ABSTRACT In papillomavirus infections, the viral genome is established as a double-
stranded DNA episome. To segregate the episomes into daughter cells during mitosis,
they are tethered to cellular chromatin by the viral E2 protein. We previously demon-
strated that the E2 proteins of diverse papillomavirus types, including bovine papilloma-
virus (BPV) and human papillomavirus 16 (HPV16), associate with the cellular DNA heli-
case ChlR1. This virus-host interaction is important for the tethering of BPV E2 to mitotic
chromatin and the stable maintenance of BPV episomes. The role of the association be-
tween E2 and ChlR1 in the HPV16 life cycle is unresolved. Here we show that an HPV16
E2 Y131A mutant (E2Y131A) had signiﬁcantly reduced binding to ChlR1 but retained tran-
scriptional activation and viral origin-dependent replication functions. Subcellular frac-
tionation of keratinocytes expressing E2Y131A showed a marked change in the localiza-
tion of the protein. Compared to that of wild-type E2 (E2WT), the chromatin-bound pool
of E2Y131A was decreased, concomitant with an increase in nuclear matrix-associated
protein. Cell cycle synchronization indicated that the shift in subcellular localization of
E2Y131A occurred in mid-S phase. A similar alteration between the subcellular pools of
the E2WT protein occurred upon ChlR1 silencing. Notably, in an HPV16 life cycle model
in primary human keratinocytes, mutant E2Y131A genomes were established as episomes,
but at a markedly lower copy number than that of wild-type HPV16 genomes, and they
were not maintained upon cell passage. Our studies indicate that ChlR1 is an important
regulator of the chromatin association of E2 and of the establishment and maintenance
of HPV16 episomes.
IMPORTANCE Infections with high-risk human papillomaviruses (HPVs) are a major
cause of anogenital and oropharyngeal cancers. During infection, the circular DNA
genome of HPV persists within the nucleus, independently of the host cell chroma-
tin. Persistence of infection is a risk factor for cancer development and is partly
achieved by the attachment of viral DNA to cellular chromatin during cell division.
The HPV E2 protein plays a critical role in this tethering by binding simultaneously
to the viral genome and to chromatin during mitosis. We previously showed that
the cellular DNA helicase ChlR1 is required for loading of the bovine papillomavirus
E2 protein onto chromatin during DNA synthesis. Here we identify a mutation in
HPV16 E2 that abrogates interaction with ChlR1, and we show that ChlR1 regulates
the chromatin association of HPV16 E2 and that this virus-host interaction is essen-
tial for viral episome maintenance.
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Human papillomaviruses (HPVs) are a large family of double-stranded DNA virusesthat infect cutaneous and mucosal epithelia, causing hyperproliferative lesions
which are at risk of progressing to anogenital, oropharyngeal, and cutaneous cancers.
Completion of the HPV life cycle is absolutely dependent on the terminal differentiation
of the infected epithelial cells, and during the productive cycle, the 8,000-bp viral
genome is maintained as extrachromosomal episomes (reviewed in reference 1).
Integration of the viral genome into the host genome is considered a risk factor for
cancer progression (2). Therefore, the mechanistic underpinnings of viral episome
establishment during infection and subsequent episomal maintenance have been the
focus of many research studies.
The viral E2 protein plays a complex role in the HPV life cycle. It is essential for viral
genome replication, via a well-studied interaction with the viral helicase E1 (3, 4), and
for transcriptional regulation of the viral oncogenes E6 and E7 (5, 6). Additionally, E2 is
required for the segregation of viral genomes into the nuclear compartment of
daughter cells during mitotic cell division, and therefore for episomal maintenance of
the viral genomes (reviewed in reference 7). E2-mediated viral genome segregation is
dependent on virus-virus and virus-host interactions. The C-terminal DNA-binding
domain (DBD) of E2 binds to speciﬁc sequences within the viral genome (8), while
during mitosis the transactivation domain (TAD) can interact with cellular chromatin by
targeting chromatin-bound host cell proteins (9–12), effectively tethering viral epi-
somes to cellular chromatin as infected cells divide. This tethering mechanism is
essential for viral episome persistence and productive HPV infection (7).
Several cellular proteins have been suggested as the chromatin-associated mitotic
receptor for E2. Interaction with the bromodomain protein Brd4 is essential for bovine
papillomavirus 1 (BPV1) E2-mediated viral genome tethering (13) but is not essential for
chromosomal attachment of many HPV E2 proteins, including those of the alpha-HPV
group (14). It has also been demonstrated that topoisomerase binding protein 1
(TopBP1) has a role in the chromatin association of HPV16 E2 during late stages of
mitosis and that interaction with TopBP1 regulates the association of E2 with cellular
chromatin (15). Interestingly, a mutant of E2 that is unable to bind TopBP1 was shown
to be transcriptionally competent but unable to support virus replication, suggesting
that the interaction between E2 and TopBP1 is important for episome establishment
(16).
Our previous work identiﬁed an interaction between BPV1 E2 and the host cell DNA
helicase ChlR1 and showed that ChlR1 interaction was conserved in HPV11 and -16 (17).
Following the identiﬁcation of a mutant BPV1 E2 protein compromised in ChlR1
binding, we demonstrated that interaction with ChlR1 is essential for mitotic attach-
ment of BPV1 E2 and for maintenance of BPV1 genomes (17). However, colocalization
studies showed that ChlR1 was not recruited to chromatin-associated E2 foci (17),
suggesting that ChlR1 does not function as the mitotic tether for the E2-viral DNA
complex but rather plays a role in bringing E2 to the chromatin during DNA replication,
prior to mitotic cell division. In support of this hypothesis, characterization of the
interaction between BPV1 E2 and ChlR1 by ﬂuorescence resonance energy transfer
revealed a more robust association during active DNA replication in S phase of the cell
cycle (18).
Following on from these studies, we have now characterized the interaction be-
tween HPV16 E2 and ChlR1 and identiﬁed a single residue in E2 that is important for
interaction with ChlR1, namely, tyrosine 131. Analysis of a ChlR1-binding-defective E2
mutant, E2Y131A, provides evidence that interaction with ChlR1 is essential for estab-
lishment and maintenance of episomal HPV16 infection and that loss of ChlR1 binding
has impacts on E2 function by altering its chromatin association during S phase.
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RESULTS
HPV16 E2 associates with ChlR1. Following on from our previous experiments
showing that BPV1 E2 associates with ChlR1 and that mutation of tryptophan 130 to
arginine (W130R) abrogates ChlR1 binding (17), we aimed to determine whether this
interaction surface is conserved in the HPV16 E2 protein. To do this, we established an
in vitro binding assay in which two N-terminal fragments of ChlR1 were cloned and
expressed as hexahistidine-tagged fusion proteins. Since an N-terminal portion of
Saccharomyces cerevisiae Chl1 between amino acids 190 and 280 was identiﬁed as
binding to BPV1 E2 in a yeast two-hybrid screen (17), we predicted that the E2 binding
region within human ChlR1 would also exist within the N terminus of ChlR1. We
therefore expressed and puriﬁed amino acids 1 to 130 and 63 to 214 of ChlR1
(His-ChlR1 1-130 and His-ChlR1 63-214, respectively) (Fig. 1A) and assessed HPV16 E2
binding following incubation of immobilized ChlR1 peptides with a whole-cell lysate of
HPV16 E2-transfected C33a cells. While HPV16 E2 bound robustly to His-ChlR1 63-214,
the E2 protein did not bind to His-ChlR1 1-130 (Fig. 1B). This provides evidence that the
E2 binding site within ChlR1 exists between amino acids 130 and 214 and that HPV16
E2 targets a domain of ChlR1 similar to that targeted by the BPV1 E2 protein.
To identify the amino acid residues in HPV16 E2 important for association with
ChlR1, we overlaid the crystal structures of the BPV1 and HPV16 E2 proteins (19, 20) and
identiﬁed amino acids within HPV16 E2 that are in close physical proximity to BPV1 E2
W130 (17) and that are surface exposed. Amino acids in HPV16 E2 (henceforth termed
E2) that ﬁt these criteria, including glutamic acid 118 (E118), aspartic acid 124 (D124),
tyrosine 131 (Y131), aspartic acid 173 (D173), and lysine 177 (K177), were mutated to
alanine residues. In addition, histidine 130 (H130) was mutated to an arginine, as this
residue aligns with BPV1 W130, which was previously mutated to an arginine to
abrogate ChlR1 binding (17) (Fig. 2A). Mutations were conﬁrmed by sequencing, and
FIG 1 HPV16 E2 associates with the N terminus of ChlR1. (A) The His-tagged ChlR1 1-130 and 63-214
peptides were expressed and puriﬁed from E. coli and then eluted from nickel afﬁnity resin in fractions
designated 1, 2, and 3. (B) Western analysis of His-ChlR1 pulldown assays of E2 expressed in C33a cell
lysates (input shown on the left). E2 associated with His-ChlR1 63-214 but not with His-ChlR1 1-130.
Molecular mass markers (in kilodaltons) are indicated to the left of each panel. UT, untransfected.
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the effects on ChlR1 binding were determined using the in vitro pulldown assay
described above (Fig. 2B and Table 1). With the exception of E2E118A, which bound
ChlR1 at levels similar to those for wild-type E2 (E2WT), most of the point mutations
created on the ChlR1 binding surface of E2 reduced binding to ChlR1 in comparison to
that with the E2WT protein. Notably, the E2Y131A mutant was severely impaired in the
ability to bind ChlR1. On average, the E2Y131A protein had an 18-fold reduction in ChlR1
binding in comparison to the E2WT protein between multiple experiments, and this
reduction in binding was consistent.
To determine whether E2Y131A was also unable to bind to ChlR1 in cells, coimmu-
noprecipitation experiments were performed. C33a cells were cotransfected with FLAG-
ChlR1 and E2WT or E2Y131A expression plasmids, and lysates were immunoprecipitated
with a FLAG-speciﬁc antibody or nonspeciﬁc IgG control antiserum. As expected, E2WT
was robustly coimmunoprecipitated with FLAG-ChlR1, but E2Y131A showed severely
reduced ChlR1 binding (Fig. 2C). Together, these data show that HPV16 E2 associates
with ChlR1 and that tyrosine 131 is essential for efﬁcient ChlR1 binding.
FIG 2 Isolation of a ChlR1-binding-defective mutant of HPV16 E2. (A) Overlay of the N-terminal transactivation domains of
BPV1 E2 (black) and HPV16 E2 (purple) (produced in PyMOL). Residue W130 in BPV1 E2 is highlighted in green. The pink
residues shown are the surface-exposed residues situated on the same surface of HPV16 E2 as W130 in BPV1 E2 that were
mutated to alanine or arginine as described in Table 1. (B) Binding of HPV16 E2 mutants to His-ChlR1 63-214 in comparison
to that of E2WT. Data from a representative experiment are shown, and a summary of all results is given in Table 1. (C) C33a
cells growing in 10-cm dishes were transfected with 2 g FLAG-ChlR1 and the E2WT or E2Y131A expression plasmid. Inputs
for coimmunoprecipitation reactions are shown in the left panels. Lysates were immunoprecipitated (IP) with FLAG or
nonspeciﬁc IgG, as indicated (right panels). Images are representative of three independent and consistent repeats.
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Mutation of Y131 within the E2 transactivation domain does not affect the
transcriptional activation or origin-dependent replication function of E2. The E2
protein is an important regulator of HPV early gene transcription and recruits the viral
E1 helicase to the origin of replication (Ori) to initiate virus replication. These functions
of E2 are essential for the virus life cycle. To determine whether E2Y131A is able to
support these viral functions and therefore whether interaction with ChlR1 plays a role
in E2-dependent virus transcription and replication, we ﬁrst utilized a synthetic tran-
scription reporter that has previously been shown to be responsive to E2 expression in
a dose-dependent manner (16). Cells were cotransfected with increasing amounts of
the E2WT- or E2Y131A-expressing plasmid. Luciferase activity and corresponding E2
protein expression were determined by use of whole-cell lysates (Fig. 3A and B). E2Y131A
consistently activated transcription to levels similar to those with E2WT, demonstrating
that mutation of Y131 and loss of ChlR1 interaction did not affect the transcriptional
activation function of the E2 protein.
To determine whether E2Y131A is able to activate virus replication to levels compa-
rable to those with E2WT, cells were transfected with plasmids containing the HPV16
origin of replication (pOri16M) or expressing hemagglutinin (HA)-tagged HPV16 E1 or
increasing amounts of either the E2WT or E2Y131A protein. Cotransfection of cells with
E2WT or E2Y131A and HA-E1 resulted in an E2 dose-dependent activation of Ori-
dependent replication above that observed with either Ori alone or Ori cotransfected
with either HA-E1 or E2 alone. Notably, there were no signiﬁcant differences in the
abilities of E2WT and E2Y131A to activate origin-dependent replication, conﬁrming that
E2Y131A is capable of activating virus replication and is as active as E2WT in this assay
(Fig. 3C and D).
Loss of ChlR1 binding results in enhanced nuclear matrix association of E2.
Analysis of the E2 protein expression levels in the transcription assay described above
suggested that the E2Y131A protein was expressed at lower levels than those of
wild-type E2 (Fig. 3B). However, this reduction in E2Y131A expression in comparison to
that of E2WT was not observed in the replication assays (Fig. 3D). This apparent
difference could be explained by the different methods used to prepare cell lysates in
these two experiments. The protein lysates in the transcription assays were prepared
using a proprietary passive lysis buffer (Promega) which is optimized for luciferase-
based assays and therefore extracts only soluble cellular proteins. In contrast, the
lysates for the replication assay were prepared with urea lysis buffer, which extracts all
cellular proteins, including chromatin-bound and insoluble proteins. We therefore
directly compared the amounts of the E2WT and E2Y131A proteins extracted with these
two different buffers. While the amount of E2WT extracted with urea lysis buffer was
similar to that extracted with passive lysis buffer, the amount of E2Y131A extracted with
urea lysis buffer was consistently greater than that extracted with passive lysis buffer.
Over 3-fold more E2Y131A was extracted with the urea buffer than with the passive lysis
buffer, while no signiﬁcant differences were observed for E2WT (Fig. 4A). These data
suggest that E2Y131A is expressed at levels similar to those of E2WT but is less soluble.
TABLE 1 Analysis of ChlR1 binding of HPV16 E2 mutants in comparison to E2WT
Mutation % E2 bounda
E118A 106.69
D124A 38.78
H130R 45.23
Y131A 5.43
D173A 80.51
K177A 36.34
aC33a cells were transfected with an E2WT or mutant E2 expression plasmid, and cell lysates were incubated
with the His-ChlR1 63-214 protein immobilized on nickel resin as described in the legend to Fig. 2. The
amount of bound E2 protein was determined by Western blotting and compared to the input by
densitometric analysis of digital images. The percentage of E2 mutant protein bound to His-ChlR1 63-214
was calculated in comparison to the E2WT binding level. The data shown are means for at least two
independent experiments.
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The difference in solubility may be due to an altered association with cellular structures,
such as chromatin or the nuclear matrix. Therefore, the subcellular localization of
E2Y131A in comparison to E2WT was also determined by immunoﬂuorescence staining.
In C33a cells, the E2WT protein was localized predominantly in the nuclear compart-
ment, with some cytoplasmic staining visible, as previously reported for formaldehyde-
ﬁxed cells (18). While E2Y131A was also localized predominantly in the nuclear compart-
ment, there was a clear increase in cytoplasmic staining (Fig. 4B). This was somewhat
surprising because the Y131A mutation is not within the known nuclear localization
signals in E2 (21).
To analyze further the differences in subcellular localization between E2WT and
E2Y131A, transfected C33a cells were fractionated into soluble cytoplasmic, membrane-
associated, soluble nuclear, chromatin-bound, and cytoskeletal/nuclear matrix frac-
tions, and the presence of E2 in each fraction was determined by Western blotting (Fig.
4C). Quantiﬁcation of these experiments revealed that there was no signiﬁcant change
in the level of E2Y131A compared to the E2WT protein in the cytoplasmic or membrane
fraction. However, there was a signiﬁcant reduction of E2Y131A in comparison to the
E2WT protein (P  0.05) in the soluble nuclear fraction and a concomitant increase in
the proportion of E2Y131A associated with the cytoskeletal and nuclear matrix fraction
(P  0.001) (Fig. 4D).
FIG 3 HPV16 E2Y131A is transcription and replication competent. (A) C33a cells were transfected with an E2-dependent luciferase reporter (p6E2-tk-Luc) alone
or in combination with increasing amounts of an E2WT- or E2Y131A-expressing plasmid. Data show mean luciferase activities and standard errors for three
independent experiments. (B) E2 protein expression in comparison to that of a -actin loading control was determined by Western blotting. (C) C33a cells were
transfected with pOri16M, which contains the HPV16 origin of replication, alone or in combination with expression plasmids for HPV16 E1 only, E2 only, or a
combination of E1 (constant amount) and E2 (0.1, 1, 10, and 100 ng). Replication was assessed by real-time PCR analysis of DpnI-digested DNA. Experiments
were performed in triplicate, and data show the means and standard deviations for intraexperimental repeats and are representative of three independent
repetitions. n.s., not signiﬁcant. (D) HPV16 HA-E1 and E2 protein expression was determined by Western blotting and compared to that of a -actin loading
control.
Harris et al. Journal of Virology
January 2017 Volume 91 Issue 1 e01853-16 jvi.asm.org 6
 o
n
 January 4, 2017 by UNIV O
F SUSSEX
http://jvi.asm.org/
D
ow
nloaded from
 
FIG 4 HPV16 E2Y131A associates with the nuclear matrix and the cellular cytoskeleton with a higher afﬁnity than that of E2WT. (A) C33a cells were
transfected with 100 ng () or 200 ng () of the E2WT or E2Y131A expression plasmid and lysed with either passive lysis buffer, to extract soluble
proteins, or urea lysis buffer, to extract all cellular proteins. Western blots for three independent repetitions were analyzed by densitometry, and
the fold change in E2 protein in comparison to the loading control was calculated. (B) C33a cells growing on coverslips in 6-well dishes were
transfected with 1 g E2WT or E2Y131A expression plasmid, and E2 protein (green) localization was assessed by immunoﬂuorescence staining. DNA
(blue) was stained with Hoechst 33342. Bar, 10 m. (C) C33a cells growing in 10-cm dishes were transfected with 2 g E2 expression plasmid (E2WT
or E2Y131A) and then fractionated to give soluble cytoplasmic (C), membrane-associated (M), soluble nuclear (N), chromatin-bound (CB), and
cytoskeletal/nuclear matrix-associated (CN) fractions. Fractions were analyzed by Western blotting to determine the subcellular localization of
E2WT and E2Y131A compared to the reference proteins Grb2 (cytoplasmic and membrane-associated fractions), Orc2 (soluble nuclear fraction),
histone 3 (chromatin-bound fraction), and vimentin (cytoskeletal fraction). (D) The percentage of E2 protein in each protein fraction was
determined by densitometry analysis of data from three independent experimental repeats, and data shown are means and standard errors of
the means. *, P  0.05; ***, P  0.001.
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Previous studies demonstrated that the association of BPV1 E2 with ChlR1 occurs
predominantly in mid-S phase, when cellular DNA replication takes place (18). We
therefore sought to determine the cell cycle dependence of the differences in E2WT and
E2Y131A subcellular localization. E2-expressing C33a cells were synchronized at the G1/S
boundary or in mid-S phase (Fig. 5A) and fractionated as described for Fig. 4. While the
subcellular localization of E2WT was not signiﬁcantly altered in G1/S- or mid-S-phase-
enriched populations of cells, there was a signiﬁcant difference in the subcellular
localization of E2Y131A (Fig. 5B). As cells progressed to mid-S phase, the amount of
nuclear soluble E2Y131A was reduced 2-fold (P  0.05), whereas the amount of cyto-
skeletal and nuclear matrix-associated E2Y131A protein was increased 2-fold (P  0.05),
in comparison to that observed in the G1/S-synchronized cells. These data indicate that
the interaction between E2 and ChlR1 is important for the solubility of E2 and that loss
of ChlR1 binding increases the less soluble, cytoskeletal and/or nuclear matrix-
associated pool of E2 protein speciﬁcally during S phase.
The fractionation experiments described thus far were performed using a biochem-
ical fractionation method that does not distinguish between cytoskeletal and nuclear
matrix-associated proteins. Therefore, to fully characterize the effect of reduced ChlR1
binding on the subcellular localization of the E2 protein and to speciﬁcally analyze the
nuclear matrix attachment of E2Y131A in comparison to that of E2WT, cells were
fractionated in situ to visualize individual cells after sequential removal of cytoplasmic,
soluble nuclear, and chromatin-bound proteins. C33a cells growing on multiple cov-
erslips in a single tissue dish were transfected with either the E2WT or E2Y131A expres-
sion plasmid. In situ fractionation was performed, and the proportion of E2-positive cells
FIG 5 Altered subcellular localization of E2Y131A in comparison to that of E2WT is S phase speciﬁc. (A) C33a cells growing in 10-cm dishes
were transfected with 2 g E2WT or E2Y131A expression plasmid and synchronized by a double thymidine block. Cells were then either
harvested (G1/S) or released for 3 h (mid-S phase) before staining with propidium iodide (PI). The cell cycle distribution was determined
by ﬂow cytometry of over 20,000 cells. (B) Synchronized cell populations were fractionated as described in the legend to Fig. 4, and the
E2 distribution was determined by Western blotting alongside markers of the subcellular fractions. The percentage of E2 protein (E2WT
or E2Y131A) in each fraction was determined by densitometry analysis of data from three independent experiments, and the data shown
are mean total E2 protein levels and standard deviations. n.s., not signiﬁcant; *, P  0.05.
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at each fractionation step was analyzed by immunoﬂuorescence staining of the E2
protein and normalized to the transfection efﬁciency calculated for the whole-cell
sample. DNA and lamin B1 protein staining was also performed on each fraction to
demonstrate the loss of chromatin following DNase I treatment and retention of the
nuclear matrix in the ﬁnal fractionation step (Fig. 6A). Removal of cytoplasmic proteins
revealed no signiﬁcant difference in the number of cells with nuclear E2WT or E2Y131A
protein. However, removal of soluble nuclear proteins, leaving chromatin-bound and
nuclear matrix-associated proteins, revealed a small but signiﬁcant increase in the
proportion of cells positive for E2Y131A compared to those positive for the E2WT protein
(P  0.05). This difference was sustained but increased in magnitude upon removal of
cellular chromatin by treatment of the cells with DNase I, leaving only nuclear matrix-
associated proteins. The proportion of cells that retained nuclear matrix-associated E2
was 2.8-fold greater for E2Y131A-transfected cells than for E2WT-transfected cells (P 
FIG 6 HPV16 E2Y131A has reduced chromatin association and increased nuclear matrix association. (A) C33a cells growing on coverslips were
transfected with 1 g E2WT- or E2Y131A-expressing plasmid and then ﬁxed with paraformaldehyde to observe whole-cell localization or
fractionated in situ as described in Materials and Methods to sequentially remove cytoplasmic proteins (leaving nuclear proteins), soluble nuclear
proteins (leaving chromatin-bound and nuclear matrix-associated proteins), and chromatin-bound proteins (leaving nuclear matrix-associated
proteins only). The E2 protein (green) and lamin B1 protein (red) in each fraction were visualized by immunoﬂuorescence staining, and DNA (blue)
was stained with Hoechst 33342. Bar, 10 m. (B) The percentage of E2-positive cells in each fraction in comparison to that in ﬁxed whole cells
was determined for E2WT- and E2Y131A-transfected populations. The data shown are means and standard errors for three independent repeats.
*, P  0.05; **, P  0.01. (C) C33a cells were transfected with a ChlR1-speciﬁc or control siRNA duplex as described in Materials and Methods, and
ChlR1 depletion was determined by Western blotting. (D) ChlR1-speciﬁc siRNA- and control siRNA-transfected cells were fractionated in situ as
described for panel A, and the percentage of E2WT-positive cells after each fractionation step in comparison to that in ﬁxed whole cells was
determined by immunoﬂuorescence staining. The data show means and standard deviations for three independent experiments. *, P  0.05.
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0.01). These data suggest that the ChlR1-binding-defective E2Y131A protein is less tightly
associated with cellular chromatin and more tightly associated with the nuclear matrix
than the E2WT protein.
To strengthen our conclusion that loss of ChlR1 binding results in a signiﬁcant
change in the solubility of nuclear E2 protein, the endogenous ChlR1 protein was
depleted from E2WT-expressing C33a cells by RNA interference. Cells were transfected
with a ChlR1-speciﬁc or nontargeting small interfering RNA (siRNA) duplex, and the
reduction in ChlR1 protein expression was conﬁrmed by Western blot analysis (Fig. 6C).
In situ fractionation of cells was performed as described for Fig. 6A. There was no
signiﬁcant difference in the proportion of E2-expressing cells following removal of
soluble cytoplasmic and nuclear proteins in comparison to that for control siRNA-
transfected cells. However, subsequent removal of chromatin-bound proteins by DNase
I treatment revealed a signiﬁcant increase in the nuclear matrix association of E2WT in
the ChlR1-depleted cells in comparison to control siRNA-transfected cells (Fig. 6D).
Together, these data indicate that disruption of the association with ChlR1, either by
mutation of E2 to prevent ChlR1 binding or by siRNA-mediated depletion of ChlR1,
leads to a change in solubility of the nuclear pool of E2. Loss of ChlR1 binding causes
decreased chromatin association of E2, which is likely important for viral genome
tethering, and increased nuclear matrix attachment.
Reduced ChlR1 binding increases E2 protein stability. It has previously been
shown that overexpression of the C-terminal domain of Brd4, which contains the E2
binding domain, dramatically increases E2 protein stability by blocking ubiquitylation
of E2 by the cullin-3 E3 ligase complex (22). In addition, interaction of E2 with TaxBP1,
a component of the cullin-3 complex, inhibits proteasome-mediated degradation of E2
(23). This regulation of E2 protein stability is not limited to interacting cellular proteins;
interactions with the E1 viral helicase and the intermediate-late protein E1^E4 also
increase E2 protein stability (24, 25), although the mechanism of E1- and E1^E4-
mediated E2 stabilization is not clear. In light of our data showing that ChlR1 interaction
regulates the chromatin- and nuclear matrix-associated cellular pools of E2, we hypoth-
esized that ChlR1 interaction also plays a role in regulating E2 protein stability, since
attachment of E2 to cellular structures, such as the nuclear matrix, might inhibit
proteasome-mediated degradation. Therefore, to determine whether the E2Y131A pro-
tein has an altered stability compared to that of E2WT, C33a cells transfected with either
E2WT or E2Y131A were treated with cycloheximide to inhibit protein synthesis, and the
E2 protein half-life was determined by analysis of E2 protein levels by Western blotting
at increasing time intervals (Fig. 7). Surprisingly, these experiments revealed a consis-
tent and dramatic increase in the half-life of E2Y131A compared to that of E2WT, from 4
h (E2WT) to 44 h (E2Y131A), even though the steady-state expression levels of E2WT and
E2Y131A were comparable (Fig. 7, 0 h). This increase in protein stability without a
noticeable difference in protein expression levels may have been due to the high levels
of protein production in these transient-transfection assays, which may mask differ-
ences in protein stability unless the continued production of protein is inhibited by
treatment with cycloheximide. Nonetheless, our data clearly show an increased stability
of E2Y131A in comparison to that of E2WT for cells treated with cycloheximide.
Association of HPV16 E2 with ChlR1 is required for high-copy-number viral
genome establishment and episome persistence. To determine the biological sig-
niﬁcance of the interaction between E2 and ChlR1 in the HPV16 life cycle, the Y131A
mutation was introduced into the E2 open reading frame of the HPV16 genome, and
recircularized viral genomes were transfected into primary human foreskin keratino-
cytes (HFKs) harvested from two independent donors. Following selection of trans-
fected cells and the establishment and expansion of cell populations, total HFK DNA
was harvested at subsequent early passages for analysis by Southern blotting (Fig. 8).
Digestion of DNA with HindIII, a noncutter of the HPV16 genome, revealed the presence
of episomes in the wild-type genome-containing cells at all three passages examined,
but episomes were barely detectable in cells harboring the E2Y131A mutant genome.
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Linearization using BamHI showed that the wild-type episomes were present at ap-
proximately 50 copies per cell at passage 1, with maintenance of episomes at a slightly
lower copy number at passages 2 and 5. In the mutant genome-containing cells, the
linearized genomes were present at approximately 5 copies per cells in the early
passage but were not detectable at passage 5, indicating episomal loss. These obser-
vations were consistent between the two donor lines.
DISCUSSION
Our ﬁndings provide novel insight into the role of ChlR1 in the HPV16 life cycle. We
show for the ﬁrst time that HPV16 E2 associates with ChlR1 and, as previously shown
for BPV1 E2 (17), that the binding site for HPV16 E2 exists in the N-terminal region of
ChlR1, between the highly conserved I and Ia helicase motifs. It is interesting that this
region of ChlR1 is unique among related iron-sulfur cluster proteins (26), suggesting
that the E2 protein evolved to speciﬁcally target ChlR1 and not related family members,
such as FANCJ and XPD. Identiﬁcation of a single amino acid mutation, at tyrosine 131
of E2, that severely impairs ChlR1 binding but does not affect the transactivation or
replication activity of E2 allowed us to dissect the role of ChlR1 in E2 function. We show
FIG 7 HPV16 E2Y131A displays enhanced protein stability in comparison to that of E2WT. (A) C33a cells
were transfected with 2 g E2WT or E2Y131A expression plasmid. Twenty-four hours following transfection,
cells were seeded into 6-well dishes and treated with cycloheximide (CHX) as described in Materials and
Methods. Cells were harvested at the stated time points and lysed in urea lysis buffer, and E2 protein
levels were determined by Western blotting. (B) Relative E2 protein levels were normalized to the -actin
loading control level at each time point following densitometric analysis of digitally imaged Western
blots. Data show means and standard deviations for three independent experimental repeats.
FIG 8 Transcription- and replication-competent HPV16 E2Y131A does not support viral genome estab-
lishment and maintenance in primary human keratinocytes. Primary human foreskin keratinocytes were
transfected with recircularized wild-type HPV16 genomes or HPV16 genomes encoding E2Y131A. Cells
were harvested at passages 1, 2, and 5, and DNAs were extracted for Southern blot analysis following
restriction enzyme digestion with DpnI and either HindIII, which did not cut the viral genomes, or BamHI,
which linearized the viral episomes. Copy number controls equivalent to 500, 50, and 5 viral copies per
cell are shown on the left. I, integrants; L, linearized; SC, supercoiled.
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that E2Y131A has a signiﬁcantly enhanced half-life and is less soluble than E2WT,
providing evidence that ChlR1 binding maintains a pool of E2 in the soluble protein
fraction, which negatively affects E2 protein stability. Since functional assays demon-
strate that the E2Y131A mutant protein is able to support transcriptional activation and
virus replication, they provide evidence that introduction of this speciﬁc mutation does
not result in misfolded E2 that precipitates within the cell. We therefore conclude that
the stability and solubility of E2 regulated by interaction with ChlR1 have biological
importance.
Several studies have identiﬁed binding partners of E2 that regulate the stability or
solubility of this essential HPV protein. Interaction with the cellular proteins Brd4 and
Tax1BP1 has been shown to stabilize E2 through inhibition of the proteasome-
mediated protein degradation pathway (22, 23). It has been demonstrated that inter-
action of HPV16 E2 with its viral binding partner, E1, increases the stability of E2 and
increases the afﬁnity of E2 for cellular chromatin (25) and that interaction with E1^E4
also increases E2 protein stability (24). Interaction with TopBP1 has been shown to
regulate the solubility of E2, but, in contrast to our ﬁndings, without affecting the
stability of E2 (15). As with the loss of ChlR1 binding, Donaldson et al. (15) showed that
depletion of TopBP1 resulted in an increase in insoluble E2, which they suggested was
due to an increase in chromatin association. However, these experiments did not
speciﬁcally distinguish between chromatin-bound proteins and nuclear matrix-
associated proteins, making it difﬁcult to conclude that the less soluble fraction of E2
protein was speciﬁcally chromatin bound rather than tightly associated with the
nuclear matrix. Nonetheless, the parallels between ChlR1- and TopBP1-binding-
defective E2 proteins are interesting and may suggest that distinct cellular pools of E2
are bound by these proteins to regulate E2 solubility and activity at distinct stages of
the cell cycle and/or virus life cycle.
The genomes of several HPV types, including HPV16, have been shown to bind with
high afﬁnity to the nuclear matrix (27). It has also been shown that the majority of the
HPV11 E2 protein is tightly associated with the nuclear matrix of transfected cells and
that very little cytoplasmic or chromatin-bound protein exists in these cells (28).
However, the steady-state distribution of HPV16 E2 is somewhat different; our ﬁndings
show that only around 30% of the cellular pool of HPV16 E2WT is associated with the
nuclear matrix, while the rest of the protein is distributed throughout the chromatin-
bound and soluble nuclear and cytoplasmic compartments of transfected cells. Inter-
estingly, it was shown previously that a conserved patch of basic amino acids within the
hinge region of HPV11 E2 is essential for strong attachment to the nuclear matrix (28).
Mutation of this patch of basic amino acids in HPV11 E2 to alanine residues resulted in
an increase in cytoplasmic E2 localization. Also, there was a loss of nuclear E2 foci,
which are thought to be important for HPV DNA replication. It was suggested from
these studies that the nuclear matrix provides a structural scaffold for E2 compartmen-
talization and that attachment to the nuclear matrix is important for viral DNA repli-
cation and viral mRNA transcription. Our ﬁndings suggest that the regulation of nuclear
distribution of the HPV16 E2 protein is more complex and that ChlR1 binding solubilizes
a pool of E2 by reducing nuclear matrix association. However, it is important to note
that the differences in subcellular localization of E2WT and E2Y131A overexpressed in
human keratinocytes may not accurately reﬂect the localization of these proteins when
they are expressed at low levels from the viral genome, and although interaction with
ChlR1 regulates the subcellular distribution of E2, our previous studies suggest that E2
expression does not affect the gross localization of ChlR1 (17, 29). Nonetheless, loss of
ChlR1 association not only increases the association of E2 with the nuclear matrix but
also increases the cytoplasmic pool of E2. Whether this increase in cytoplasmic E2 is due
to increased protein stability or to a loss of retention in the nucleus is not clear, but our
data show that the ability of ChlR1 to regulate subcellular pools of E2 is essential for
viral episome maintenance, consistent with our previous ﬁndings for BPV1.
Our previous studies showed that ChlR1 is important for sister chromatid cohesion
establishment and thus supports high-ﬁdelity chromosome segregation during mitosis
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(29). It has since been demonstrated that ChlR1 is important for heterochromatin
organization and that its depletion causes decreased chromatin compaction at peri-
centric and telomeric chromosomal regions (30). Furthermore, in vitro assays showed
that the ChlR1 helicase efﬁciently unwinds DNA structures that contain G-quadruplex
(G4) structures (31), which are frequently found in heterochromatin (32). This ability to
resolve G4 structures that inevitably stall replication forks may help to explain why
ChlR1-deﬁcient cells are highly sensitive to DNA cross-linking agents, such as cisplatin
and mitomycin C, that stall the replication machinery (33). In yeast, the ChlR1 homo-
logue, Chl1, genetically interacts with the alternative replication factor C complex
protein RFC-Ctf18, which is involved in sister chromatid cohesion establishment and
replication fork stabilization (34). In addition, ChlR1 is known to associate with repli-
cation fork proteins, such as proliferating cell nuclear antigen (PCNA) and the ﬂap
endonuclease, Fen1 (35, 36), and is important for replication recovery following DNA
damage (37). Given these roles in replication fork stability and replication-coupled DNA
damage resolution, the association between the HPV E2 protein and ChlR1 may
conceivably result in recruitment of E2 to stalled replication complexes, although it
should be noted that we have not demonstrated that E2 directly binds ChlR1. None-
theless, our data show that a loss of ChlR1 binding results in reduced nuclear matrix
association of E2 and in its increased solubility. Indeed, we previously showed that BPV1
E2 speciﬁcally targets ChlR1 during active DNA replication in S phase (18), which likely
explains why the shift in soluble nuclear E2 to insoluble nuclear matrix-associated E2
following abrogation of ChlR1 binding is signiﬁcant in cells synchronized in S phase and
not in cells synchronized at the G1/S boundary. Put together, our data suggest that E2
targets ChlR1 during DNA replication to allow positioning of the E2-HPV genome
complex at the replication fork when ChlR1 is recruited to difﬁcult-to-replicate sites.
This reduces the nuclear matrix association of the E2 protein and facilitates loading of
the viral genomes onto cellular chromatin prior to mitotic segregation. This mechanism
of E2-HPV genome attachment to cellular chromatin is essential for the establishment
and persistence of high-copy-number HPV episomes.
MATERIALS AND METHODS
Plasmids. The HPV16 E2 expression plasmid pCMV-16E2 was a kind gift from Iain Morgan, University
of Virginia, and was used as a template for site-directed mutagenesis, using Pfu Ultra II HS DNA
polymerase (Agilent), to introduce the mutations described in Table 1. pCMV-FLAG-ChlR1 expresses
N-terminally FLAG-tagged ChlR1 (29) and was obtained from Jill Lahti, St. Jude Children’s Research
Hospital, and used as a template to clone amino acids 1 to 130 and 63 to 214 of ChlR1 into the NcoI- and
EcoRI-digested pHIS-TEV bacterial expression vector (gifted by Jim Naismith, University of St. Andrews,
United Kingdom [38]). The E2-dependent transcription reporter p6E2-tk-Luc encodes six E2 binding sites
upstream of a thymidine kinase enhancer and carries the ﬁreﬂy luciferase open reading frame (gifted by
Iain Morgan). For viral replication assays, plasmids p16OriM, which contains the HPV16 origin of
replication, and pHPV16-HA-E1, which expresses hemagglutinin (HA)-tagged HPV16 E1 under the control
of a cytomegalovirus (CMV) promoter, were also obtained from Iain Morgan (39).
The HPV16 114/K genome, cloned into pUC19, was a kind gift from Ethel-Michele de Villiers (DKFZ,
Germany) and was used as a template to introduce T3147-to-G and A3148-to-C mutations to encode E2Y131A
by use of a QuikChange II XL kit (Agilent Technologies), the primer 5=-GATGGAGACATATGCAATACAAT
GCATGCTACAAACTGGACACATATATAT-3=, and its reverse complement. Plasmids extracted from the
resulting clones were sequenced throughout the HPV genome to ensure that no other mutations had
been introduced.
Bacterial protein expression and in vitro pulldown assays. Escherichia coli BL21(DE3) was trans-
formed with the pHISTEV-ChlR1 1-130 and pHISTEV-ChlR1 63-214 expression plasmids. Protein expres-
sion was induced by addition of 0.5 mM IPTG (isopropyl--D-thiogalactopyranoside) to log-phase
bacterial cultures and incubation at 37°C for 4 h in an orbital shaker. Cell pellets were resuspended in lysis
buffer (50 mM Na2PO4, pH 6.5, 150 mM NaCl, 1% [wt/vol] lysozyme, 5 mM dithiothreitol [DTT], and
protease inhibitor cocktail) and lysed by sonication at a 35% amplitude twice for 20 s each. Lysates were
cleared by centrifugation and ﬁltration, added to a 50% Ni2 resin slurry (1 ml lysate/100 l resin), and
then incubated for 2 h at 4°C with agitation. Unbound lysate was removed, and the resin was washed
three times with 500 l wash buffer (50 mM Na2PO4, pH 6.5, 150 mM NaCl, 5 mM DTT, and protease
inhibitor cocktail) and resuspended in an equal volume of the same buffer. Puriﬁed proteins were
assessed by SDS-PAGE and Coomassie blue staining.
Cell culture. C33a cells were maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing
high glucose and L-glutamine and supplemented with 10% fetal bovine serum (FBS) (Sigma). Transfec-
tions were carried out with XtremeGene HP (Roche) at a DNA/reagent ratio of 2:1. Cells were synchro-
nized by a double thymidine block, and synchrony was conﬁrmed following ﬁxation of cells in 70%
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ethanol before incubation with propidium iodide and RNase A and analysis by ﬂow cytometry as
previously described (18). For siRNA-mediated depletion experiments, cells were ﬁrst transfected with
siRNA duplexes by electroporation using an Amaxa system. A total of 4  106 cells were resuspended in
100 l electroporation solution (Mirus), and cells were pipetted into a 0.2-cm electroporation cuvette
containing 20 l of 20 M ChlR1-speciﬁc siRNA targeting the 3= UTR of ChlR1 (target sequence,
5=-AGUCACUCCUUCAGUAGAAUU-3=) or a nontargeting scramble control (siGENOME nontargeting siRNA
2; Dharmacon). Cells were electroporated using program S-005, immediately plated into a 10-cm-
diameter dish, and allowed to recover overnight before transfection with E2-expressing plasmid DNA by
use of XtremeGene as detailed above.
Establishment of HPV16 genome-containing primary HFKs and Southern blotting. The trans-
fection of normal primary human foreskin keratinocytes (HFKs) isolated from neonatal foreskin epithelia
(ethical approval number 06/Q1702/45) was performed in S. Roberts’s laboratory by J. L. Parish as
previously described (40). To eliminate donor-speciﬁc effects, HFKs from two independent donors were
used. Following G418 drug selection, cell colonies were pooled and expanded on terminally gamma-
irradiated J2-3T3 ﬁbroblasts in E medium containing epidermal growth factor. Viral genomes were
extracted from each line and sequenced to ensure appropriate establishment of wild-type and mutant
genomes. Organotypic rafts were prepared and cultured for 14 days in E medium without epidermal
growth factor, as previously described (40). Southern blotting was performed as previously described
(41).
In vitro pulldown assays. C33a cells were seeded at a density of 2  106 into 10-cm tissue culture
dishes and transfected with 2 g E2 expression plasmid. Cells were lysed at 24 h posttransfection in 300
l IP lysis buffer (17, 18), and 100 l cleared lysate was mixed with equal amounts of His-ChlR1 1-130-
or His-ChlR1 63-214-bound nickel resin in a total reaction volume of 300 l made up with IP binding
buffer (17, 18). Samples were incubated for 16 h at 4°C. Unbound lysate was removed, and the resin was
washed three times with 500 l wash buffer. Bound proteins were analyzed by SDS-PAGE and Western
blotting.
Coimmunoprecipitation. C33a cells were transfected and incubated for 24 h. Coimmunoprecipita-
tion experiments were performed as previously described (17, 18), using a FLAG-speciﬁc antibody (M2;
Sigma) or nonspeciﬁc mouse IgG (Sigma). Coimmunoprecipitated proteins were separated by SDS-PAGE
and detected by Western blotting using the FLAG antibody and the E2-speciﬁc antibody TVG261
(Abcam).
Transcription assay. Transcription assays were performed as previously described (18, 42). C33a cells
(2  105) were seeded into each well of a six-well plate and transfected with an E2 expression plasmid
(100, 250, 500, or 1,000 ng) and the luciferase reporter p6E2-tk-Luc (100 ng). Fireﬂy luciferase activity was
determined for cell lysates prepared using passive lysis buffer (Promega) following the addition of
luciferase assay reagent (Promega). Protein expression was conﬁrmed by Western blotting.
Replication assay. Replication assays were performed as described previously (42). Brieﬂy, 2.5  105
C33a cells were seeded into each well of a 6-well plate. Cells were transfected with 25 ng pOri16M and
expression plasmids for HA-E1 (600 ng) alone or in combination with E2WT or E2Y131A (0.1 ng, 1 ng, 10
ng, or 100 ng). Forty-eight hours following transfection, cells were harvested and DNA extracted using
Hirt lysis buffer (0.6% SDS, 10 mM EDTA). DNA was then puriﬁed by phenol-chloroform/isoamyl alcohol
extraction followed by ethanol precipitation, and the DNA was digested with DpnI. Replicated pOri16M
was quantiﬁed by real-time PCR as previously described (39). For Western blot analysis of exogenous
proteins (E1 and E2), cells transfected in parallel were lysed in urea lysis buffer (50 mM Tris-HCl, pH 7.5,
8 M urea, and 14 mM -mercaptoethanol). Protein concentrations were measured by the Bradford assay,
and 25 g protein was separated by SDS-PAGE before Western blotting.
Subcellular fractionation. At 48 h posttransfection, C33a cells were harvested by trypsinization and
counted. Cells (5  106) were pelleted and fractionated by sequential lysis by use of a subcellular
fractionation kit (Thermo Scientiﬁc). Fractions were analyzed by Western blotting for E2 and proteins
used as markers of the cellular fractions (Grb2, soluble cytoplasmic fraction; Orc2, soluble nuclear
fraction; histone H3, chromatin-associated fraction; and vimentin, cytoskeletal and nuclear matrix-
associated fraction).
In situ fractionation. C33a cells were seeded into plates containing multiple poly-D-lysine-coated
coverslips and transfected with the HPV16 E2WT- or E2Y131A-expressing plasmid. At 48 h posttransfection,
coverslips were removed and placed in 6-well plates. Cells were sequentially extracted to remove cellular
fractions as previously described (43). After each step, one coverslip for each transfection was removed
and ﬁxed in 3.7% formaldehyde to allow analysis of the retained proteins by immunoﬂuorescence
staining.
Immunoﬂuorescence microscopy. Formaldehyde-ﬁxed cells were permeabilized by incubation in
0.2% Triton X-100 in phosphate-buffered saline (PBS) for 10 min (with the exception of in situ-
fractionated cells) before blocking by incubation in 20% heat-inactivated goat serum plus 1% bovine
serum albumin (BSA) in PBS for 1 h at room temperature (RT). Cells were then incubated with speciﬁc
primary antibodies diluted in blocking solution for 1 h at RT before washing in PBS 3 times for 5 min each.
Cells were then incubated with Alexa Fluor-conjugated secondary antibodies (Invitrogen) diluted 1:1,000
in blocking solution for 1 h at RT in the dark and then washed again in PBS 4 times for 5 min each.
Hoechst 33342 (5 g/ml) in PBS was added to the ﬁnal wash to stain DNA. Stained coverslips were
mounted in Fluoroshield (Sigma), and cells were visualized with a Nikon E600 epiﬂuorescence micro-
scope ﬁtted with a DXM1200F digital camera.
Protein stability assay. Protein stability assays were carried out as previously described (27). Cells
were harvested 0, 2, 4, 8, 12, and 24 h following the addition of 10 g/ml cycloheximide (Sigma) and
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lysed in urea lysis buffer (50 mM Tris-HCl, pH 7.5, 8 M urea, and 14 mM -mercaptoethanol). Relative
amounts of protein were quantiﬁed using a Fusion FX digital chemiluminescence detection system and
software, and protein half-lives were calculated with GraphPad Prism 4 software, using a one-phase
exponential decay model.
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